Background Atopic dermatitis (AD) is an inflammatory skin disease with significant unmet
need. Blockade of the OX40–OX40 ligand (OX40L) costimulation pathway by targeting …

Background Health literacy (HL) is essential for patients with multiple atopic diseases to
improve their health, given the complexity of their disease and treatment regimens. Objective …

Clinical trials have shown that baricitinib, an oral selective Janus kinase 1/2 inhibitor, is
effective for the treatment of moderate-to-severe atopic dermatitis. However, daily practice …

Background Severity‐associated factors in atopic dermatitis (AD) have focussed on early
onset, concomitant atopic diseases, markers of Th2‐shifted inflammation and filaggrin …

There is a lack of knowledge concerning loneliness and psychiatric disorders other than
anxiety and depression in patients with atopic dermatitis. This cross-sectional study was …

Background Studies on the association between severity of atopic dermatitis (AD) and
lifestyle factors in adults have not been conducted in the Netherlands to date. Aim To …

Background Atopic dermatitis (AD) and hand eczema often co‐occur, particularly among
adults. Objectives To examine the interplay between AD and hand eczema in the general …

To the Editor: The COVID-19 pandemic might disproportionately impact patients with atopic
dermatitis (AD), a chronic inflammatory disorder with immune dysregulation. We conducted …

Hand eczema is a common condition that affects the hands and can have significant
negative impacts on quality of life and socio-economic consequences. Unfortunately …

Atopic dermatitis (AD), a chronic inflammatory skin disease, has far-reaching impacts on
several aspects of health-related quality of life, including disease-specific symptoms …